Navigation Links
Stroke study sheds light on left-right brain divide

Research into the effects of strokes has furthered our understanding of the different roles of the left and right sides of our brains. A study led by the University of Exeter has highlighted differences in the ability of people to perform basic tasks, depending on whether the left or right sides of their brains have been damaged by a stroke. The research identified the role of the right side of the brain in noticing and correcting errors.

The research focused on damage to the frontal lobes, the front part of the brain which is known to be responsible for aspects of language, decision making and learning. The team found that people who had damage to their left side were more likely to realise they had made a mistake, and then correct it, compared to those who had damage to their right frontal lobes. Funded by the Wellcome Trust, the research is now published in the journal Brain.

Dr Tim Hodgson, neuro-psychologist at the University of Exeter and lead researcher on this study, said: ‘We know that suffering a stroke in the left frontal region can affect aspects of speech and language, but this research highlights, for the first time, the additional challenges that people with right frontal-lobe damage might face in everyday life.’

23 people, each with frontal lobe damage, performed a ‘rule-switching’ task which involved learning rules linking the colour of a symbol on a computer screen with a movement to the left or right. All the participants made mistakes during the task, but it was those with right-brain damage who most frequently failed to spot their errors and had difficulty keep track of the changing task rules. The group with damage to the left frontal lobes corrected 68% of mistakes in the test, whereas people with right-brain damage only made corrections to 30% of their errors. This suggests that people who suffer damage to their right frontal lobe following a stroke may struggle in everyday situations which require attention to b
'"/>

Source:University of Exeter


Page: 1 2

Related biology news :

1. Mystery Blood Vessel Disorder Implicated In Mini Strokes
2. Stroke treatment a step closer after trial
3. Stroke symptoms common among general population
4. Bioartificial kidney under study at MCG
5. W.M. Keck Foundation funds study of friendly microbes
6. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
7. Genome-wide mouse study yields link to human leukemia
8. Clam embryo study shows pollutant mixture adversely affects nerve cell development
9. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
10. Same mutation aided evolution in many fish species, Stanford study finds
11. Sequencing of marine bacterium will help study of cell communication

Post Your Comments:
(Date:11/24/2009)...ands of years it has been prescribed by traditiona...rom headaches and stomach pain to fever and flu. ,... University have been able to scientifically prove... otherwise known as Brazilian mint. , Testing th...ed by researcher Graciela Rocha was able to show t...
(Date:11/24/2009)...s have crystallised a protein that may help gut ba...tein could be used by probiotic producers to ident...to people. , "Probiotics need to interact with ce...d if they attach to surfaces in the gut they are m...eir activity," says Dr Nathalie Juge from the Inst...
(Date:11/24/2009)...and the American College of Medical Toxicology (AC... publication of the Journal of Medical Toxicology...ng in March 2010. It was previously published by ...urnal of Medical Toxicology , an international, pe... science and practice of medical toxicology. The ...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2A sticky solution for identifying effective probiotics 2Springer and the American College of Medical Toxicology to work together 2Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis 52567 1Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis 52567 2Injection Reverses Heart Attack Damage 4771 1Injection Reverses Heart Attack Damage 4771 2Injection Reverses Heart Attack Damage 4771 3American Joint Replacement Registry Announced 52562 1American Joint Replacement Registry Announced 52562 2
...entified a key signaling molecule in the brain tha...g for cocaine. Their finding could offer an import...ircuiting that adaptive process. , In an article i...o Bonci and colleagues established that a short pr... region central to the adaptation to addictive dru...
...s shed more light on the multi-decade debate about...ng at them. , You don,t have to watch your legs an...are. For decades scientists have debated two optio...flow hypothesis says that the brain monitors signa...ly to contract, and uses this to predict where the...
...d "peak fish" and fishermen,s nets will be hauling...l action to stem the global tide of over fishing, ... British Columbia. Dr. Daniel Pauly says the crisi...c proof than about attitude and political will. ,...gh-profile political champion like a Bono or Mande...
Other Biology News:How the brain learns to become addicted 2How does the brain know what the right hand is doing? 2Hooked on fishing, and we're heading for the bottom, says scientist 2Hooked on fishing, and we're heading for the bottom, says scientist 3
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswi...GN ) today announced that it has received notice f...mpany,s common stock will be,suspended as of Novem...the,Securities and Exchange Commission, which will...aq, unless the company files an appeal to the Nasd...
(Date:11/24/2009)..., REYKJAVIK, Iceland, November 24 /PRNewswi...GN ) today announced the approval of all of its,"f... the District of Delaware,(the "Bankruptcy Court")...relief under Chapter 11 of the United States Bankr...he orders issued by the Bankruptcy Court allow the...
(Date:11/24/2009)... SHANGHAI, Nov. 24 /PRNewswire-Asia/ -- Shanghai B... Administration (SFDA) has approved the,investigat...lin project,(Nodlin), an innovative insulin formul...Biolaxy to initiate its first phase I clinical stu...ic of high blood glucose and poor,metabolism. The ...
(Date:11/24/2009)...imary efficacy endpoint has been met for patients ...ancer, , QUEBEC CITY, Nov. 24 /PRNewswire-Fir...SX: AEZ) (the "Company"), a global biopharmaceutic...gy, today announced positive efficacy data from a ...conjugate, AEZS-108 (formerly AN-152), in patients...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...TON BEACH, California, and AMSTERDAM, May 28 ,Agen...s, today announced its,strong support of Genentech...ocket No. FDA-2008-P-0638-0001/CP petitions that a... scientific and regulatory standards. In response,...er of support to the U.S.,Food and Drug Administra...
...France, May 28 Poxel is a research integrated,pha...erono a division of,Merck KGaA, Germany, following...in diabetes research and development. It aims to a...ses (with a primary focus on Type 2,diabetes) from...fore,out-licensing these projects to major pharmac...
...G, Md., May 28 GenVec, Inc. (Nasdaq: GNVC ) a... agreement with a single institutional investor fo... and warrants to purchase 9,615,385 shares of its ...ants are being offered in units consisting of one ...e share of common stock at a price of $0.624 per u...
Other Biology Technology:Agendia Supports Genentech's Citizen's Petition Urging FDA to Hold In-Vitro Diagnostic Tests to One Set of Scientific and Regulatory Standards 2Poxel SAS Set up to Find Innovative Solutions for Metabolic Diseases Management 2GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants 2GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants 3
RABBIT (BABY) COMPLEMENT LYOPHILISED from AbD Serotec
Rabbit Anti-Human ZO-1 Antibody, Unconjugated from Lab Vision
Mouse Anti-Human Myeloid Marker Monoclonal Antibody, Unconjugated, Clone BM-1 from Santa Cruz Biotechnology, Inc.
5x C'GATE STOCK STABILIZING REAGENT from AbD Serotec
Biology Products: